Moritz E. Hansen

Moritz E. Hansen

Auto-generated profile, based on publicly available information

Moritz E. Hansen

Laboratorium für Organische Chemie ETH Zürich Vladimir-Prelog-Weg 3 8093 Zürich Switzerland

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 July 2021 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
FPFelix Pultar
Felix Pultar
MHMoritz E. Hansen
Moritz E. Hansen
SWSusanne Wolfrum
Susanne Wolfrum
LBLennard Böselt
Lennard Böselt
RFRicardo Fróis-Martins
Ricardo Fróis-Martins
ECErick Moran Carreira
Erick Moran Carreira

10 June 2022 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
MHMoritz E. Hansen
Moritz E. Hansen
SYSamuel O. Yasmin
Samuel O. Yasmin
SWSusanne Wolfrum
Susanne Wolfrum
ECErick Moran Carreira
Erick Moran Carreira
We report the first total syntheses of tricyclic mutanobactins A and B, lipopeptides incorporating a thiazepanone, isolated from Streptococcus mutans, a member of the human oral microbiome. A rapid, solid‐phase peptide synthesis (SPPS) based route delivers these natural products from a cascade of cyclization reactions. This versatile process was also employed in a streamlined synthesis of mutanobactin D. Additionally, we provide an independent synthesis of a truncated mutanobactin A analog, utilizing a novel thiazepanone amino acid building block.

27 March 2025 in ACS Central Science
Verified
Journal Article
Open access
LLLukas Lüthy
Lukas Lüthy
LTLeon Gabor Sacha Thies
Leon Gabor Sacha Thies
KBKonstantin Nikolaus Beitl
Konstantin Nikolaus Beitl
MHMoritz Hansen
Moritz Hansen
JMJoshua McManus
Joshua McManus
ECErick Moran Carreira
Erick Moran Carreira
Mutanofactins are a family of natural products produced by Streptococcus mutans from the human oral microbiome. We report a unified approach to all mutanofactins by developing a total synthesis amenable to diversification. The key to success for the most complex members, mutanofactins 607 and 697, was an acyl ketene based strategy. Access to the family enabled comprehensive biological profiling, where we demonstrate that all mutanofactins are biofilm promoting in Streptococcus mutans. Experiments were extended to other inhabitants of the oral microbiome for the first time: Streptococcus gordonii and Streptococcus oralis, two early colonizers, were similarly affected with mutanofactins being biofilm promoting. Conversely, Veillonella dispar and Fusobacterium nucleatum showed little to no reaction to mutanofactins. Biophysical investigations based on quartz crystal microbalance with dissipation monitoring and atomic force microscopy reveal a previously unknown mucin-mutanofactin 697 interaction. Incubation of a mucin layer with mutanofactin 697 induces a morphology change within the mucin layer, which promotes bacterial adhesion and biofilm formation. This unique property of mutanofactin 697 might be key to early stages of biofilm formation in the human oral microbiome. Combined, an interdisciplinary approach consisting of total synthesis, microbiology and biophysical characterization provides insight into the roles of mutanofactins in the oral microbiome.

1 March 2021 in Urologic Oncology: Seminars and Original Investigations
Verified
Journal Article
Closed access
WDWilliam C. Daly
William C. Daly
PHPaul K.J. Han
Paul K.J. Han
MHMatthew Hayn
Matthew Hayn
SRStephen T. Ryan
Stephen T. Ryan
MHMoritz H. Hansen
Moritz H. Hansen
JSJesse D. Sammon
Jesse D. Sammon

1 June 2021 in Journal of Urology
Verified
Journal Article
Closed access
WDWilliam C. Daly
William C. Daly
JLJoshua A. Linscott
Joshua A. Linscott
PHPaul K. J. Han
Paul K. J. Han
MHMatthew H. Hayn
Matthew H. Hayn
MHMoritz H. Hansen
Moritz H. Hansen
JSJesse D. Sammon
Jesse D. Sammon
Purpose:Medicaid expansion under the Affordable Care Act (ACA) occurred almost concurrently with 2012 USPSTF recommendations against PSA screening. Here the relative influence on PSA screening rate...

10 June 2022 in Angewandte Chemie
Verified
Journal Article
Open access
MHMoritz E. Hansen
Moritz E. Hansen
SYSamuel O. Yasmin
Samuel O. Yasmin
SWSusanne Wolfrum
Susanne Wolfrum
ECErick Moran Carreira
Erick Moran Carreira
We report the first total syntheses of tricyclic mutanobactins A and B, lipopeptides incorporating a thiazepanone, isolated from Streptococcus mutans, a member of the human oral microbiome. A rapid, solid‐phase peptide synthesis (SPPS) based route delivers these natural products from a cascade of cyclization reactions. This versatile process was also employed in a streamlined synthesis of mutanobactin D. Additionally, we provide an independent synthesis of a truncated mutanobactin A analog, utilizing a novel thiazepanone amino acid building block.